Skip to main content

Bacillus Calmette-Guérin

  • Reference work entry
  • First Online:
  • 31 Accesses

Synonyms

BCG; Mycobacterium bovis BCG

Definition

Bacillus Calmette-Guérin (BCG) is a mycobacterium belonging to the Mycobacterium tuberculosis complex. It is a live attenuated organism and generally nonpathogenic for healthy human subjects. Originally developed as a vaccine against tuberculosis, since the mid-1970s, it is increasingly used as a successful active immunotherapeutic agent in the treatment of nonmuscle-invasive bladder cancer.

Characteristics

Microbiological Background on BCG and Tuberculosis Vaccination

BCG is an attenuated derivative of virulent Mycobacterium bovis (M. bovis), the causative pathogen of bovine tuberculosis. The name of BCG acknowledges the contributions of two French researchers Albert Calmette, a microbiologist, and Jean-Marie Camille Guérin, a veterinarian. Those two, between 1908 and 1921, passaged a virulent strain of M. bovisin an attempt to generate a vaccine against tuberculosis in humans. By using a continuous in vitro passage and a special...

This is a preview of subscription content, log in via an institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   2,499.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD   3,999.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  • Brandau S, Suttmann H (2007) Thirty years of BCG immunotherapy for non-muscle invasive bladder cancer: a success story with room for improvement. Biomed Pharmacother 61(6):299–305

    Article  CAS  PubMed  Google Scholar 

  • Huber CH, Wolfel T (2004) Immunotherapy of cancer: from vision to standard clinical practice. J Cancer Res Clin Oncol 130(7):367–374

    Article  CAS  PubMed  Google Scholar 

  • Mostowy S, Tsolaki AG, Small PM et al (2003) The in vitro evolution of BCG vaccines. Vaccine 21(27–30):4270–4274

    Article  CAS  PubMed  Google Scholar 

  • Seya T, Akazawa T, Uehori J et al (2003) Role of toll-like receptors and their adaptors in adjuvant immunotherapy for cancer. Anticancer Res 23(6a):4369–4376

    CAS  PubMed  Google Scholar 

  • Sylvester RJ, Meijden AP, van derLamm DL (2002) Intravesical bacillus Calmette-Guerin reduces the risk of progression in patients with superficial bladder cancer: a meta-analysis of the published results of randomized clinical trials. J Urol 168(5):1964–1970

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Sven Brandau .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2017 Springer-Verlag Berlin Heidelberg

About this entry

Cite this entry

Brandau, S. (2017). Bacillus Calmette-Guérin. In: Schwab, M. (eds) Encyclopedia of Cancer. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-46875-3_514

Download citation

Publish with us

Policies and ethics